Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

Near Term Catalyst:
LAUNCHES:

1. Elite Pharmaceuticals Launches Phendimetrazine Tartrate Tablets USP, 35 mg with Glenmark Pharma.

2. Elite Pharmaceuticals Launches Isradipine 2.5 mg and 5 mg Capsules with Glenmark Pharma.

3. Elite Pharmaceuticals Launches Trimipramine Maleate 25, 50, 100 mg Tablets with Glenmark Pharma.

4. Elite Pharmaceuticals Launches Generic Adderall


APPROVALS:

1. Elite Pharmaceuticals Receives FDA Approval For Generic OxyContin®

2. Elite Pharmaceuticals Receives FDA Approval For The Monster SunGen #2 ANDA


FILINGS:

1. Elite Pharmaceuticals And SunGen Pharma File ANDA For IR Antibiotic Generic Product.

2. Elite Pharmaceuticals And SunGen Pharma File ANDA For Second IR Antibiotic Generic Product.

3. Elite Pharmaceuticals And SunGen Pharma File Second Monster CNS ANDA Generic Product


PARTNERSHIPS:

1. Elite Pharmaceuticals Announces Strategic Marketing Alliance With SunGen Pharma.

2. Elite Pharmaceuticals Announces Strategic Marketing Alliance For Generic Norco® Tablets.


PATENTS

1. Elite Pharmaceuticals Granted New Patent For Abuse Deterrent Technology.